Cohen Investment Advisors LLC Has $426,000 Stock Position in CME Group Inc. $CME

Cohen Investment Advisors LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 8.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,547 shares of the financial services provider’s stock after selling 142 shares during the quarter. Cohen Investment Advisors LLC’s holdings in CME Group were worth $426,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CME. Wayfinding Financial LLC acquired a new position in shares of CME Group during the 1st quarter worth $25,000. Webster Bank N. A. grew its stake in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Highline Wealth Partners LLC grew its stake in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its stake in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Barclays lowered their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday. UBS Group lowered their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Wednesday. Piper Sandler raised their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Six investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and a consensus target price of $275.17.

CME Group Price Performance

Shares of CME Group stock opened at $264.94 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s 50-day simple moving average is $269.26 and its 200-day simple moving average is $271.06. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The firm has a market cap of $95.48 billion, a P/E ratio of 25.65, a price-to-earnings-growth ratio of 5.56 and a beta of 0.41.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business earned $2.56 EPS. The firm’s revenue was up 10.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.